Trials / Conditions / Pulmonary Neoplasms

Pulmonary Neoplasms

17 registered clinical trials studyying Pulmonary Neoplasms — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy NCT06809946	University Medical Center Groningen	Phase 2
Recruiting	Precision Lung Cancer Survivorship Care Intervention NCT05857995	Jerod L Stapleton, PhD	N/A
Completed	Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® NCT05011890	UNC Lineberger Comprehensive Cancer Center	N/A
Active Not Recruiting	Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation NCT04699188	Novartis Pharmaceuticals	Phase 1 / Phase 2
Completed	Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung NCT02410603	Mayo Clinic	—
Terminated	MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) NCT02673021	Mayo Clinic	N/A
Completed	RejuvenAir Lobectomy for Safety and Histology NCT02483052	CSA Medical, Inc.	Phase 1 / Phase 2
Terminated	Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma NCT02549638	Mayo Clinic	—
Completed	A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System NCT02370303	Mayo Clinic	—
Completed	Study of Arsenic Trioxide in Small Cell Lung Cancer NCT01470248	Emory University	Phase 2
Completed	A Phase I Study of iPS Cell Generation From Patients With COPD NCT01860898	Mayo Clinic	N/A
Completed	Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath NCT00922155	Chang Gung Memorial Hospital	N/A
Terminated	Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease NCT00241267	University Hospital, Tours	—
Terminated	Protocol for Radiofrequency Ablation of Pulmonary Neoplasms NCT00232128	Oncology Specialties, Alabama	N/A
Completed	Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplat NCT00290953	Sanofi	Phase 2 / Phase 3
Completed	Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer ( NCT00132639	Haruhiko Fukuda	Phase 2
Completed	A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in NCT00042679	Eli Lilly and Company	Phase 2